FI107232B - Menetelmä peräsuolen kautta annettavaksi tarkoitettujen triatsolijohdannaisia sisältävien koostumusten valmistamiseksi - Google Patents

Menetelmä peräsuolen kautta annettavaksi tarkoitettujen triatsolijohdannaisia sisältävien koostumusten valmistamiseksi Download PDF

Info

Publication number
FI107232B
FI107232B FI924639A FI924639A FI107232B FI 107232 B FI107232 B FI 107232B FI 924639 A FI924639 A FI 924639A FI 924639 A FI924639 A FI 924639A FI 107232 B FI107232 B FI 107232B
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
preparation
composition according
glycerides
weight
Prior art date
Application number
FI924639A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI924639A (fi
FI924639A0 (fi
Inventor
Walter Fries
Gerhard Simon
Guenther Pfaff
Joerg Pfitzner
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of FI924639A0 publication Critical patent/FI924639A0/fi
Publication of FI924639A publication Critical patent/FI924639A/fi
Application granted granted Critical
Publication of FI107232B publication Critical patent/FI107232B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI924639A 1991-10-15 1992-10-14 Menetelmä peräsuolen kautta annettavaksi tarkoitettujen triatsolijohdannaisia sisältävien koostumusten valmistamiseksi FI107232B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4134125A DE4134125C2 (de) 1991-10-15 1991-10-15 Triazol-Derivate enthaltende pharmazeutische Zusammensetzungen zur rektalen Applikation
DE4134125 1991-10-15

Publications (3)

Publication Number Publication Date
FI924639A0 FI924639A0 (fi) 1992-10-14
FI924639A FI924639A (fi) 1993-04-16
FI107232B true FI107232B (fi) 2001-06-29

Family

ID=6442729

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924639A FI107232B (fi) 1991-10-15 1992-10-14 Menetelmä peräsuolen kautta annettavaksi tarkoitettujen triatsolijohdannaisia sisältävien koostumusten valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0537729B1 (zh)
JP (1) JPH05294830A (zh)
KR (1) KR930007446A (zh)
AT (1) ATE150970T1 (zh)
CA (1) CA2080566C (zh)
DE (2) DE4134125C2 (zh)
DK (1) DK0537729T3 (zh)
ES (1) ES2100998T3 (zh)
FI (1) FI107232B (zh)
GR (1) GR3023552T3 (zh)
HU (1) HU213202B (zh)
IL (1) IL103398A (zh)
MX (1) MX9205898A (zh)
MY (1) MY108576A (zh)
NO (1) NO923992L (zh)
NZ (1) NZ244734A (zh)
TW (1) TW258661B (zh)
ZA (1) ZA927907B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
GR79307B (zh) * 1982-06-09 1984-10-22 Pfizer
DE3307217A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte 1,3-diazolyl-2-propanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel

Also Published As

Publication number Publication date
EP0537729B1 (en) 1997-04-02
DE4134125A1 (de) 1993-04-22
TW258661B (zh) 1995-10-01
NZ244734A (en) 1994-12-22
HU213202B (en) 1997-03-28
IL103398A0 (en) 1993-03-15
GR3023552T3 (en) 1997-08-29
ATE150970T1 (de) 1997-04-15
ES2100998T3 (es) 1997-07-01
CA2080566C (en) 1998-02-17
ZA927907B (en) 1993-04-21
DE69218718D1 (de) 1997-05-07
JPH05294830A (ja) 1993-11-09
DE69218718T2 (de) 1997-08-07
DE4134125C2 (de) 1995-02-02
CA2080566A1 (en) 1993-04-16
NO923992L (no) 1993-04-16
FI924639A (fi) 1993-04-16
EP0537729A1 (en) 1993-04-21
MY108576A (en) 1996-10-31
NO923992D0 (no) 1992-10-14
IL103398A (en) 1997-08-14
DK0537729T3 (da) 1997-09-22
HU9203236D0 (en) 1992-12-28
MX9205898A (es) 1993-05-01
KR930007446A (ko) 1993-05-20
HUT65417A (en) 1994-06-28
FI924639A0 (fi) 1992-10-14

Similar Documents

Publication Publication Date Title
EP0189788B1 (de) Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika
DE833611T1 (de) Zusammensetzung, die ein in einem glasbildenden träger gelösten wirkstoff enthalt und ein verfahren zu deren herstellung
JP4750270B2 (ja) アルテミニシニン及び／又はアルテミシニン誘導体を含有する製薬学的活性組成物
NZ230505A (en) Treating skin injuries using thromboxane a2 receptor antagonists
PL189358B1 (pl) Kompozycja farmaceutyczna do podawania doustnego
JP2002537258A5 (zh)
JPH01224316A (ja) 医薬製剤
PL196821B1 (pl) Sól olanzapiny i jej zastosowanie
DE202007019385U1 (de) Pharmazeutische Zusammensetzungen, umfassend Clopidogrel
FI107232B (fi) Menetelmä peräsuolen kautta annettavaksi tarkoitettujen triatsolijohdannaisia sisältävien koostumusten valmistamiseksi
RU96119364A (ru) Производная бензамида, композиции, содержащие упомянутую производную, и их применение
US6265425B1 (en) Combination of a RAMBA and a tocopherol
US5360612A (en) Pharmaceutical compositions containing triazole derivatives for rectal administration
ITMI990454A1 (it) Composizioni a rilascio controllato di betaistina
AU647674B2 (en) Pharmaceutical compositions containing triazole derivatives for rectal administration
RU2007141564A (ru) Аминоалкиламидометилзамещенные производные 2-(4-сульфониламино)-3-гидрокси-2н-хроман-6-ила и лекарственные средства, содержащие эти соединения
NZ230914A (en) Use of a thromboxane a2 receptor antagonist in composition for treating migraine
NL194463C (nl) Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat.
KR20060100117A (ko) 알파-리포산을 포함한 안정성이 증진된 경구 투여용 약제조성물
US4617306A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist
EP0444546B1 (en) Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents
CZ291041B6 (cs) Čípek pro rektální podání
NL8200746A (nl) Verbinding met antitussive activiteit, werkwijze ter bereiding daarvan en toepassing.
DE69935881T2 (de) Bis-Indolylmaleimide zur therapeutischen Behandlung von Nieren-Funktionsstörungen
US4612310A (en) Antirheumatically active suppositories

Legal Events

Date Code Title Description
MA Patent expired